Abstract
Seventy-four patients were treated with 150 mg/day amitriptyline (AT) to determine possible correlations between clinical improvement, demographic variables, and AT and nortriptyline (NT) plasma levels. Plasma level determinations after 2 and 6 weeks of treatment revealed that moderately significant correlations existed between AT plasma levels and clinical improvement, dosage intake, age, weight, sex, and coffee intake. Some of these findings were more pronounced after 2, and some after 6 weeks of treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Psychiatric Association (1980) DSM-III: Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington, DC, pp 205–224
Amin MM, Cooper R, Khalid R, Lehmann HE (1978) A comparison of desipramine and amitriptyline plasma levels and therapeutic response. Psychopharmacol Bull 14: 45–46
Amsterdam J, Brunswick D, Mendels J (1980) The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels. Am J Psychiatry 137: 653–662
Braithwaite RA, Goulding R, Theano G, Bailey J, Coppen A (1972) Plasma concentration of amitriptyline and clinical response. Lancet 1: 1297–1300
Coppen A, Montgomery S, Ghose K, Rama Rao VA, Bailey J (1978) Amitriptyline plasma-concentration and clinical effect. Lancet 1: 63–66
Corona GL, Pinelli P, Zerbi F, Fenoglio L, Santagostino G, Frattini P, Cucchi ML (1980) Amitriptyline, nortriptyline plasma levels and clinical response in women with affective disorders. Pharmakopsychiatrie 13: 102–110
Downing RW, Rickels K (1982) Coffee consumption, cigarette smoking and the reporting of drowsiness in anxious patients treated with benzodiazepines or placebo. Acta Psychiatr Scand 64: 398–408
Draper NR, Smith H (1981) Applied regression analysis. John Wiley and Sons, New York, 299–300
Dutt JE (1981) On the clinical response-serum level relationship for antidepressants. I. Amitriptyline. Psychopharmacol Bull 17: 42–55
Giedke H, Gaetner H, Breyer-Pfaff U (1980) Plasma levels of amitriptyline and nortriptyline, clinical response and psychophysiological variables in depression. Drug Res 30: 1201
Hamilton MA (1960) Rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56–62
Hucker HB, Stauffer SC (1977) Rapid, sensitive gas-liquid chromatographic method for determination of amitriptyline and nortriptyline in plasma using a nitrogen-sensitive detector. J Chromatogr 138: 437–442
Johnstone EC, Bourne RC, Crow TJ, Frith CD, Gamble S, Lofthouse R, Owen F, Owens DGC, Robinson J, Stevens M (1981) The relationship between clinical response, psychophysiological variables and plasma levels of amitriptyline and diazepam in neurotic outpatients. Psychopharmacology 72: 233–240
Jungkunz G, Kuss HJ (1980) On the relationship of nortriptyline: amitriptyline ratio to clinical improvement of amitriptyline-treated depressive patients. Pharmakopsychiatrie 13: 111–116
Kupfer DJ, Hanin I, Spiker DG, Grau T, Coble P (1977) Amitriptyline plasma levels and clinical response in primary depression. Clin Pharmacol Ther 22: 904–911
Kupfer DJ, Hanin I, Spiker D, Neil J, Coble P, Grau T, Nevar C (1978) Amitriptyline plasma levels and clinical response in primary depression. II Commun Psychopharmacol 2: 441–450
Linnoila M, George L, Guthric S, Leventhal B (1981) Effect of alcohol consumption and cigarette smoking on antidepressant levels of depressed patients. Am J Psychiatry 138: 841–842
Mendlewicz J, Linkowski P, Rees JA (1980) A double-blind comparison of dothiepin and amitriptyline in patients with primary affective disorder: Serum levels and clinical response. Br J Psychiatry 136: 154–160
Nies A, Robinson DS, Friedman MJ, Green R, Cooper TB, Ravaris CL, Ives JO (1977) Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiatry 134: 790–793
Norman TR, Burrows GD, Maguire KP, Rubinstein G, Scoggins BA, Davies B (1977) Cigarette smoking and plasma nortriptyline levels. Clin Pharmacol Ther 121: 453–456
Raskin A, Schulterbrandt JG, Reating N, McKeon JJ (1970) Differential response to chlorpromazine, imipramine and placebo. Arch Gen Psychiatry 23: 164–173
Rickels K, Downing RW, Spaeth H (1973) The physician depression scale (PDS): A factor analytic study. Pharmakopsychiatr Neuropsychopharmakol 6: 280–286
Risch SC, Huey LY, Janowsky DS (1979) Plasma levels of tricyclic antidepressants and clinical efficacy: Review of the literature. J Clin Psychiatry 40: 4–16
Robinson DS, Cooper TB, Ravaris CL, Ives JO, Nies A, Bartlett D, Lamborn KR (1979) Plasma tricyclic drug levels in amitriptylinetreated depressed patients. Psychopharmacology 63: 223–231
Weise CC, Stein MK, Pereira-Ogan J, Csanalosi I, Rickels K (1980) Amitriptyline once daily vs. three times daily in depressed outpatients. Arch Gen Psychiatry 37: 555–560
Ziegler VE, Biggs JT (1977) Tricyclic plasma levels: Effect of age, race, sex, and smoking. JAMA 238: 2167–2169
Ziegler VE, Clayton PJ, Biggs JT (1977) A comparison study of amitriptyline and nortriptyline with plasma levels. Arch Gen Psychiatry 34: 607–612
Ziegler VE, Co BT, Taylor JR, Clayton PJ, Biggs JT (1976) Amitriptyline plasma levels and therapeutic response. Clin Pharmacol Ther 19: 795–801
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rickels, K., Weise, C., Case, G. et al. Tricyclic plasma levels in depressed outpatients treated with amitriptyline. Psychopharmacology 80, 14–18 (1983). https://doi.org/10.1007/BF00427486
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00427486